Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.2430 EUR
450.46 M EUR
2.51 B EUR
About Wuxi Biologics (Cayman) Inc.
Sector
Industry
CEO
Zhi Sheng Chen
Website
Headquarters
Wuxi
Founded
2014
ISIN
US98260N1081
Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. It operates through the Biologics and XDC segments. The company was founded on February 27, 2014, and is headquartered in Wuxi, China.
Related stocks
Wuxi Biologics (2269): Incredible long-term opportunity! Wuxi Biologics (2269): HKEX:2269
Wuxi Biologics, a Chinese biotech research company listed on the Hong Kong Stock Exchange, presents a complex investment scenario. It's crucial to note we're dealing with the Hong Kong Dollar, not the US dollar. The comprehensive analysis on the weekly chart sug
2269.HK is going to fly ~ (1st target: 77.8, 2nd target: 90.05)2269.HK has experienced a long decline for more than 1 year due to local and oversea government policies, although its P&L has growth a lot. 2269.HK is going to complete a head and shoulder pattern within the last 70 days, and highly likely to fly in the near term. The first target will be 77.8 and
Wuxi Biologics Cayman Inc (2269 - HK) - 5th wave upWuxi Biologics Cayman Inc (2269 - HK) is in 5th wave up of major 5th wave of C wave up in daily time frame. It is now in 5th wave up after sharp 4th wave ended just above wave 1 territory. It also be possible that extension is on the way. But conservatively it is now in 5th wave progress with small
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy